Nuveen Asset Management’s Wave Life Sciences WVE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $6.85M | Buy |
553,439
+137,159
| +33% | +$1.7M | ﹤0.01% | 1822 |
|
|
2024
Q3 | $3.41M | Buy |
416,280
+89,390
| +27% | +$733K | ﹤0.01% | 2168 |
|
|
2024
Q2 | $1.63M | Buy |
326,890
+103,540
| +46% | +$517K | ﹤0.01% | 2479 |
|
|
2024
Q1 | $1.38M | Buy |
223,350
+15,579
| +7% | +$96.1K | ﹤0.01% | 2562 |
|
|
2023
Q4 | $1.05M | Sell |
207,771
-5,067
| -2% | -$25.6K | ﹤0.01% | 2710 |
|
|
2023
Q3 | $1.22M | Buy |
212,838
+6,579
| +3% | +$37.8K | ﹤0.01% | 2491 |
|
|
2023
Q2 | $751K | Buy |
+206,259
| New | +$751K | ﹤0.01% | 2774 |
|
|
2022
Q2 | – | Sell |
-139,637
| Closed | -$338K | – | 3411 |
|
|
2022
Q1 | $338K | Buy |
139,637
+2,734
| +2% | +$6.62K | ﹤0.01% | 3101 |
|
|
2021
Q4 | $443K | Sell |
136,903
-11,692
| -8% | -$37.8K | ﹤0.01% | 3102 |
|
|
2021
Q3 | $844K | Buy |
148,595
+4,711
| +3% | +$26.8K | ﹤0.01% | 3051 |
|
|
2021
Q2 | $958K | Buy |
143,884
+3,280
| +2% | +$21.8K | ﹤0.01% | 3026 |
|
|
2021
Q1 | $788K | Sell |
140,604
-8,781
| -6% | -$49.2K | ﹤0.01% | 2968 |
|
|
2020
Q4 | $1.18M | Buy |
149,385
+23,639
| +19% | +$186K | ﹤0.01% | 2746 |
|
|
2020
Q3 | $1.07M | Buy |
125,746
+21,063
| +20% | +$179K | ﹤0.01% | 2659 |
|
|
2020
Q2 | $1.09M | Sell |
104,683
-5,394
| -5% | -$56.2K | ﹤0.01% | 2592 |
|
|
2020
Q1 | $1.03M | Buy |
110,077
+32,218
| +41% | +$302K | ﹤0.01% | 2502 |
|
|
2019
Q4 | $624K | Sell |
77,859
-2,423
| -3% | -$19.4K | ﹤0.01% | 2854 |
|
|
2019
Q3 | $1.65M | Buy |
80,282
+2,557
| +3% | +$52.5K | ﹤0.01% | 2490 |
|
|
2019
Q2 | $2.03M | Buy |
+77,725
| New | +$2.03M | ﹤0.01% | 2435 |
|